Answers are grounded in this paper and cite their sources.
A precursor of a β-peptide derivative transforms into a hydrogelator and forms supramolecular hydrogels upon phosphatase-catalyzed dephosphorylation. This new strategy works in vitro and in vivo (see image). The enzymatic hydrogelation in vivo indicates that the β-peptide-based hydrogel exhibits a longer lifetime than that of α-peptide hydrogel in a subcutaneous environment. Such an excellent in vivo stability renders the β-peptide-based hydrogel as a potential candidate for biomedical applications.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: